Perfluoroalkyl substances and kidney function in chronic kidney disease, anemia, and diabetes

References

• Mehdi U Toto RD Anemia, diabetes, and chronic kidney disease Diabetes Care 2009 32 7 1320 1326 19564475
   PubMed Web of Science ®Google Scholar
• Stauffer ME Fan T Prevalence of anemia in chronic kidney disease in the United States PLoS One 2014 9 1 e84943 24392162
   PubMed Web of Science ®Google Scholar
• Al-Khoury S Afzali B Shah N Diabetes, kidney disease and anaemia: time to tackle a troublesome triad? Int J Clin Pract 2007 61 2 281 289 17263715
   PubMed Web of Science ®Google Scholar
• Fine LG Orphanides C Norman JT Progressive renal disease: the chronic hypoxia hypothesis Kidney Int Suppl 1998 65 65 S74 S78 9551436
   PubMed Web of Science ®Google Scholar
• Ow CPC Ngo JP Ullah MM Hilliard LM Evans RG Renal hypoxia in kidney disease: Cause or consequence? Acta Physiol 2018 222 4 e12999
   PubMed Web of Science ®Google Scholar
• Lau C Anitole K Hodes C Lai D Pfahles-Hutchens A Seed J Perfluoroalkyl acids: a review of monitoring and toxicological findings Toxicol Sci 2007 99 2 366 394 17519394
   PubMed Web of Science ®Google Scholar
• Krafft MP Riess JG Perfluorocarbons: Life Sciences and Biomedical Uses J Polymer Science: Part A: Polymer Chemistry 2007 45 1185 1198
   Web of Science ®Google Scholar
• Kennedy GL Butenhoff JL Olsen GW The toxicology of perfluorooctanoate Crit Rev Toxicol 2004 34 4 351 384 15328768
   PubMed Web of Science ®Google Scholar
• Butenhoff J Costa G Elcombe C Toxicity of ammonium perfluorooctanoate in male cynomolgus monkeys after oral dosing for 6 months Toxicol Sci 2002 69 1 244 257 12215680
   PubMed Web of Science ®Google Scholar
• Winquist A Steenland K Perfluorooctanoic acid exposure and thyroid disease in community and worker cohorts Epidemiology 2014 25 2 255 264 24407430
   PubMed Web of Science ®Google Scholar
• Barry V Winquist A Steenland K Perfluorooctanoic acid (PFOA) exposures and incident cancers among adults living near a chemical plant Environ Health Perspect 2013 121 11–12 1313 1318 24007715
   PubMed Web of Science ®Google Scholar
• Benbrahim-Tallaa L Lauby-Secretan B Loomis D Carcinogenicity of perfluorooctanoic acid, tetrafluoroethylene, dichloromethane, 1,2-dichloropropane, and 1,3-propane sultone Lancet Oncol 2014 15 9 924 925 25225686
   PubMed Web of Science ®Google Scholar
• Stein CR Savitz DA Elston B Thorpe PG Gilboa SM Perfluorooctanoate exposure and major birth defects Reprod Toxicol 2014 47 15 20 24803403
   PubMed Web of Science ®Google Scholar
• Seals R Bartell SM Steenland K Accumulation and clearance of perfluorooctanoic acid (PFOA) in current and former residents of an exposed community Environ Health Perspect 2011 119 1 119 124 20870569
   PubMed Web of Science ®Google Scholar
• Brede E Wilhelm M Göen T Two-year follow-up biomonitoring pilot study of residents’ and controls’ PFC plasma levels after PFOA reduction in public water system in Arnsberg, Germany Int J Hyg Environ Health 2010 213 3 217 223 20488749
   PubMed Web of Science ®Google Scholar
• Zhang Y Beesoon S Zhu L Martin JW Biomonitoring of perfluoroalkyl acids in human urine and estimates of biological half-life Environ Sci Technol 2013 47 18 10619 10627 23980546
   PubMed Web of Science ®Google Scholar
• Olsen GW Burris JM Ehresman DJ Half-life of serum elimination of perfluorooctanesulfonate, perfluorohexanesulfonate, and perfluorooctanoate in retired fluorochemical production workers Environ Health Perspect 2007 115 9 1298 1305 17805419
   PubMed Web of Science ®Google Scholar
• Li Y Fletcher T Mucs D Half-lives of PFOS, PFHxS and PFOA after end of exposure to contaminated drinking water Occup Environ Med 2018 75 1 46 51 29133598
   PubMed Web of Science ®Google Scholar
• Spahn DR Blood substitutes. Artificial oxygen carriers: perfluorocarbon emulsions Crit Care 1999 3 5 R93 R97 11094488
   PubMed Web of Science ®Google Scholar
• Riess JG Perfluorocarbon-based oxygen delivery Artif Cells Blood Substit Immobil Biotechnol 2006 34 6 567 580 17090429
   PubMed Web of Science ®Google Scholar
• Henkel-Honke T Oleck M Artificial oxygen carriers: a current review Aana J 2007 75 3 205 211 17591302
   PubMedGoogle Scholar
• Hosgood SA Nicholson ML The role of perfluorocarbon in organ preservation Transplantation 2010 89 10 1169 1175 20393403
   PubMed Web of Science ®Google Scholar
• Reznik ON Bagnenko SF Loginov IV Iljina VA Ananyev AN Moysyuk YG The use of oxygenated perfluorocarbonic emulsion for initial in situ kidney perfusion Transplant Proc 2008 40 4 1027 1028 18555106
   PubMed Web of Science ®Google Scholar
• Kuroda Y Morita A Fujino Y Successful 48-hour preservation of ischemically damaged canine pancreas by the two-layer (UW solution/ perfluorochemical) method Transplant Proc 1994 26 2 557 558 8171553
   PubMed Web of Science ®Google Scholar
• Atias S Mizrahi SS Shaco-Levy R Yussim A Preservation of pancreatic tissue morphology, viability and energy metabolism during extended cold storage in two-layer oxygenated University of Wisconsin/ perfluorocarbon solution Isr Med Assoc J 2008 10 4 273 276 18548980
   PubMed Web of Science ®Google Scholar
• Squifflet J-P Ledinh H de Roover A Meurisse M Pancreas Preservation for Pancreas and Islet Transplantation: A Minireview Transplant Proc 2011 43 9 3398 3401 22099806
   PubMed Web of Science ®Google Scholar
• Humphreys MR Ereth MH Sebo TJ Can the kidney function as a lung? Systemic oxygenation and renal preservation during retrograde perfusion of the ischaemic kidney in rabbits BJU Int 2006 98 3 674 679 16925771
   PubMed Web of Science ®Google Scholar
• Gronow G Kelting T Skrezek C Vd Plas J Bakker JC Oxygen transport to renal tissue: effect of oxygen carriers Adv Exp Med Biol 1987 215 117 128 3314401
   PubMedGoogle Scholar
• Giménez-Bastida JA Surma M Zieliński H In vitro evaluation of the cytotoxicity and modulation of mechanisms associated with inflammation induced by perfluorooctanesulfonate and perfluorooctanoic acid in human colon myofibroblasts CCD-18Co Toxicol In Vitro 2015 29 7 1683 1691 26142696
   PubMed Web of Science ®Google Scholar
• Palm F Nordquist L Renal tubulointerstitial hypoxia: cause and consequence of kidney dysfunction Clin Exp Pharmacol Physiol 2011 38 7 474 480 21545630
   PubMed Web of Science ®Google Scholar
• Körner A Eklöf AC Celsi G Aperia A Increased renal metabolism in diabetes. Mechanism and functional implications Diabetes 1994 43 5 629 633 8168637
   PubMed Web of Science ®Google Scholar
• Rosenberger C Khamaisi M Abassi Z Adaptation to hypoxia in the diabetic rat kidney Kidney Int 2008 73 1 34 42 17914354
   PubMed Web of Science ®Google Scholar
• Franzén S Pihl L Khan N Gustafsson H Palm F Pronounced kidney hypoxia precedes albuminuria in type 1 diabetic mice Am J Physiol Renal Physiol 2016 310 9 F807 F809 26936871
   PubMed Web of Science ®Google Scholar
• Frisbee SJ Brooks AP Maher A The C8 health project: design, methods, and participants Environ Health Perspect 2009 117 12 1873 1882 20049206
   PubMed Web of Science ®Google Scholar
• Steenland K Tinker S Shankar A Ducatman A Association of perfluorooctanoic acid (PFOA) and perfluorooctane sulfonate (PFOS) with uric acid among adults with elevated community exposure to PFOA Environ Health Perspect 2010 118 2 229 233 20123605
   PubMed Web of Science ®Google Scholar
• Cain L Shankar A Ducatman AM Steenland K The relationship between serum uric acid and chronic kidney disease among Appalachian adults Nephrol Dial Transplan 2010 25 11 3593 3599
   PubMed Web of Science ®Google Scholar
• Levey AS Stevens LA Schmid CH A new equation to estimate glomerular filtration rate Ann Intern Med 2009 150 9 604 612 19414839
   PubMed Web of Science ®Google Scholar
• Hancock JB Davidson S Guinn C Zachary R Using liquid ventilation to improve lung function in patients with respiratory distress syndrome: a comprehensive review of the literature Aana J 2004 72 3 218 224 15208970
   PubMedGoogle Scholar
• Eckardt K-U Bernhardt WW Weidemann A Role of hypoxia in the pathogenesis of renal disease Kidney Int 2005 68 99 S46 S51
   Google Scholar
• Norman JT Fine LG Intrarenal oxygenation in chronic renal failure Clin Exp Pharmacol Physiol 2006 33 10 989 996 17002678
   PubMed Web of Science ®Google Scholar
• Shankar A Xiao J Ducatman A Perfluoroalkyl chemicals and chronic kidney disease in US adults Am J Epidemiol 2011 174 8 893 900 21873601
   PubMed Web of Science ®Google Scholar
• Thomas S Rampersad M Anaemia in diabetes Acta Diabetol 2004 41 Suppl 1 s13 s17 15103543
   PubMed Web of Science ®Google Scholar
• Bosman DR Winkler AS Marsden JT Macdougall IC Watkins PJ Anemia with erythropoietin deficiency occurs early in diabetic nephropathy Diabetes Care 2001 24 3 495 499 11289474
   PubMed Web of Science ®Google Scholar
• Deray G Heurtier A Grimaldi A Launay Vacher V Isnard Bagnis C Anemia and diabetes Am J Nephrol 2004 24 5 522 526 15452405
   PubMed Web of Science ®Google Scholar
• Fishbane S Besarab A Mechanism of increased mortality risk with erythropoietin treatment to higher hemoglobin targets Clin J Am Soc Nephrol 2007 2 6 1274 1282 17942772
   PubMed Web of Science ®Google Scholar
• Drüeke TB Locatelli F Clyne N Normalization of hemoglobin level in patients with chronic kidney disease and anemia N Engl J Med 2006 355 20 2071 2084 17108342
   PubMed Web of Science ®Google Scholar
• Singh AK Szczech L Tang KL Correction of anemia with epoetin alfa in chronic kidney disease N Engl J Med 2006 355 20 2085 2098 17108343
   PubMed Web of Science ®Google Scholar
• Dhingra R Winquist A Darrow LA Klein M Steenland K A Study of Reverse Causation: Examining the Associations of Perfluorooctanoic Acid Serum Levels with Two Outcomes Environ Health Perspect 2017 125 3 416 421 27529882
   PubMed Web of Science ®Google Scholar